Zobrazeno 1 - 10 of 291 pro vyhledávání: '"G, Michlmayr"'
1
Präoperative autologe Blutkollektion unter Erythropoietinstimulation
Autor: J. Hochreiter, H. Jakubek, W. Hohenwallner, D. Nietsche, J. Oswald, G. Michlmayr
Publikováno v: Zeitschrift für Orthopädie und ihre Grenzgebiete. 130:519-523
In a randomised study we have evaluated the influence of erythropoietin (EPO) on the yield of autologous blood in elective surgery (total hip replacement). The study was performed placebo controlled in 82 patients: 25 patients received 200 IE EPO/kg
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2c69d4eeef9675581fc2578385e4b3dd
https://doi.org/10.1055/s-2008-1039663
Zobrazit plný text záznamu
2
Blastenkrise der chronischen myeloischen Leukämie: Ergebnisse mit Vindesin-Prednisolon
Autor: Nitsche D, Tschurtschenthaler G, G. Michlmayr, M. Stöger
Publikováno v: DMW - Deutsche Medizinische Wochenschrift. 110:1936-1939
Nine patients with blast crises of chronic myeloid leukaemia were treated with a combination of vindesine and prednisolone. Vindesine, 2 mg/m2, was administered intravenously on two successive days each week and prednisolone, 60 mg/m2, orally once da
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ee66ba74b7adb9f87dc0926cf977ec9
https://doi.org/10.1055/s-2008-1069116
Zobrazit plný text záznamu
3
Rekombinantes Interferon α-2c bei Ph-positiver chronischer myeloischer Leukämie: Ergebnisse einer multizentrischen Phase-II-Studie
Autor: T. Fluckinger, G. Gastl, G. Michlmayr, Christoph Duba, D. Niederwieser, J. Thaler, Heinz Huber, I. Schiller, K. Abbrederis, A. Lang, Thomas Kühr, H. Gadner, R. Weitgasser, Georg Kemmler, C. Gattringer, C. Huber, H. Seewann, W. Fereberger, Michael A. Fridrik, Hubert Hausmaninger
Publikováno v: DMW - Deutsche Medizinische Wochenschrift. 116:721-728
In a Phase II study, 82 patients with Philadelphia chromosome(Ph)-positive chronic myelogenous leukaemia were treated with 3.5 million I.U./d of recombinant interferon alpha-2c (rIFN). 73 patients have so far been evaluated (42 male, 31 female, mean
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5cac24e2712da2ca1d97176ae0a965a8
https://doi.org/10.1055/s-2008-1063670
Zobrazit plný text záznamu
4
Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia
Autor: Helmut Gadner, E. Pittermann, G. Michlmayr, D. Lutz, Martin Mistrik, R. Heinz, Elisabeth Koller, Heidrun Karlic, O. Krieger
Publikováno v: Annals of Hematology. 70:75-78
The PML/RAR alpha fusion RNA can be detected in acute promyelocytic leukemia (APL), cytogenetically characterized by the translocation t(15;17). Our study included ten newly diagnosed patients with APL who were investigated during the course of their
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c631c3078d387b9283d6964878c024c
https://doi.org/10.1007/bf01834383
Zobrazit plný text záznamu
8
[Preoperative autologous blood collection under erythropoietin stimulation. Preliminary results in patient selection, erythropoietin dosage and administration]
Autor: J, Hochreiter, D, Nietsche, J, Oswald, H, Jakubek, G, Michlmayr, W, Hohenwallner
Publikováno v: Zeitschrift fur Orthopadie und ihre Grenzgebiete. 130(6)
In a randomised study we have evaluated the influence of erythropoietin (EPO) on the yield of autologous blood in elective surgery (total hip replacement). The study was performed placebo controlled in 82 patients: 25 patients received 200 IE EPO/kg
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bdaa6d912245e23be0b1077a80fcaf89
https://pubmed.ncbi.nlm.nih.gov/1492458
Zobrazit plný text záznamu
9
Toxicity and preliminary results with a new eight-drug regimen (CEOP-IMVP-DEXA) in the treatment of aggressive lymphomas
Autor: M. A. Fridrik, G. Michlmayr, M. Lehnert, H. L. Seewann, R. Haidinger, H. Hausmaninger
Publikováno v: Hematological oncology. 9(4-5)
A combination of two non-cross-resistant regimens, CEOP and IMVP-Dexa given every 4 weeks, three to six times according to response was tested in patients with untreated histological proven high and intermediate grade non-Hodgkin's lymphoma. To date
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f1f4ed8827275699dfee488afaefdd
https://pubmed.ncbi.nlm.nih.gov/1743623
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje